Updated on 7 September 2026
Smart Workflow Automation for Clinical Trial Management
CEO at Ergobyte Informatics S.A.
Thessaloniki, Greece
About
With its workflow automation component, Ergobyte employs Business Process Modeling Notation (BPMN), an open, well-accepted industry standard, enhances it with custom-built modules that use machine learning to adapt decisions, and couples it with openEHR, an open standard for the structuring of data in electronic health records.
The system addresses a wide range of needs arising within a healthcare or research facility, such as ward management, therapeutic protocols, nursing care plans, clinical trials, etc. Any procedure can be formalized into executable diagrams, with benefits stemming from pervasive decision support and implementation transparency.
Reference: P. Natsiavas, T. G. Stavropoulos, A. Pliatsios, H. Karanikas, G. I. Gavriilidis, V. K. Dimitriadis, G. Nikolaidis, S. Nikolopoulos, P. Skapinakis, E. Thireos and I. Kompatsiaris, “Using Business Process Management Notation to Model Therapeutic Prescription Protocols: the PrescIT Approach”, Medical Informatics Europe (MIE) 2021, Poster Presentation, 29-31 May 2021
Topic
- Clinical trials: HORIZON-HLTH-2027-02-DISEASE-01-two-stage Innovative healthcare interventions for non-communicable diseases
- Clinical trials: HORIZON-MISS-2027-02-CANCER-03 Phase 1 including first-in-human clinical trials to test biomarker-guided medicines or multi-modal treatment interventions for patients with rare or very rare cancers or cancer subtypes
- Clinical trials: HORIZON-HLTH-2027-01-DISEASE-10 Prevention and management of chronic non-communicable diseases in children and young people (GACD)
- Clinical trials: HORIZON-HLTH-2027-02-DISEASE-14-two-stage Clinical trials for advancing innovative interventions for neurodegenerative diseases
Type
- Partner seeks Consortium/Coordinator
Similar opportunities
Project cooperation
Clinical Studies for Horizon Europe Cluster Health 2027
- Partner seeks Consortium/Coordinator
- Clinical trials: HORIZON-HLTH-2027-02-DISEASE-01-two-stage Innovative healthcare interventions for non-communicable diseases
- Clinical trials: HORIZON-HLTH-2027-02-DISEASE-14-two-stage Clinical trials for advancing innovative interventions for neurodegenerative diseases
- Clinical trials: HORIZON-HLTH-2027-01-DISEASE-10 Prevention and management of chronic non-communicable diseases in children and young people (GACD)
- Clinical trials: HORIZON-MISS-2027-02-CANCER-03 Phase 1 including first-in-human clinical trials to test biomarker-guided medicines or multi-modal treatment interventions for patients with rare or very rare cancers or cancer subtypes
Juan Abolafia
Head EU office at Fundació de Recerca Clínic Barcelona-Institut d'Investigacions Biomèdiques August Pi i Sunyer
Barcelona, Spain
Project cooperation
Medical-grade remote monitoring and digital endpoints for NCD and neurodegenerative clinical trials
- Partner seeks Consortium/Coordinator
- Clinical trials: HORIZON-HLTH-2027-02-DISEASE-01-two-stage Innovative healthcare interventions for non-communicable diseases
- Clinical trials: HORIZON-HLTH-2027-02-DISEASE-14-two-stage Clinical trials for advancing innovative interventions for neurodegenerative diseases
Kai Gand
Grants Manager at Corsano Health
The Hague, Netherlands
Project cooperation
- Clinical trials: HORIZON-HLTH-2027-02-DISEASE-14-two-stage Clinical trials for advancing innovative interventions for neurodegenerative diseases
Ilias Nikolinakos
EU Grants and Funding Coordinator at Elpen Pharmaceutical Co. Inc.
Athens, Greece